Skip to main content
. 2020 Aug 11;20:750. doi: 10.1186/s12885-020-07182-9

Table 2.

Univariate and multivariate Cox proportional hazard models for overall survival

Variable Univariate Analysis
HR (95% CI)
P value Multivariable Analysis
HR (95% CI)a
P value
Gender
 Female N/A N/A 1.0 (Reference)
 Male N/A N/A 1.33 (1.00–1.78) .053
Age
  ≤ 70 N/A N/A 1.0 (Reference)
  > 70 N/A N/A 1.41 (1.01–1.97) .04
Pathologic Stage
 T0 N/A N/A 1.0 (Reference)
 T1 N/A N/A 1.36 (0.53–3.54) .53
 T2 N/A N/A 2.85 (1.33–6.12) .007
 T3 N/A N/A 3.13 (1.44–6.83) .004
CCI
 0–3 N/A N/A 1.0 (Reference)
 4+ N/A N/A 1.63 (1.11–2.40) .01
NLR
  < 5 1.0 (Reference) 1.0 (Reference)
  ≥ 5 1.80 (1.22–2.64) .003 2.13 (1.41–3.22) .002
PLR
  < 144.4 1.0 (Reference) N/A N/A
  ≥ 144.4 1.02 (0.78–1.34) .889 N/A N/A
LMR
  < 2.9 1.0 (Reference) N/A N/A
  ≥ 2.9 0.82 (0.63–1.08) .156 N/A N/A
Perineural Invasion
 No N/A N/A 1.0 (Reference)
 Yes N/A N/A 1.51 (0.99–2.31) .055
Complication Grade (3–4)b N/A N/A 2.37 (1.57–3.57) <.0001
Positive Nodes N/A N/A 1.07 (1.03–1.12) .002

amodel includes: age, gender, pathologic stage, CCI, complication score, NLR, nodal and perineural invasion status. b Clavien-Dindo Classification of Surgical Complications

Abbreviations: CCI Charlson Comorbidity Score, NLR neutrophil to lymphocyte ratio, PLR platelet to lymphocyte ratio, LMR lymphocyte to monocyte ratio